glp-1 obesity drug news today september 2025 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Care Beyond GLP-1: the next wave
Description
ETD 12.4%
Ken Fujioka, Department of Nutrition and Metabolic Research, Scripps Clinic, La Jolla, California, and a SCALE clinical trial investigator
We closely monitor any potential side effects and work collaboratively with our patients to ensure optimal outcomes
Are all generic semaglutide brands equally effective
At our practice, we offer semaglutide as a part of personalized medical weight loss programs, helping patients achieve their aesthetic and wellness goals under the careful supervision of our expert medical team
